PMS57 ASSOCIATION OF CLINICAL REMISSION AND NORMALIZED PATIENT REPORTED OUTCOMES: A VALIDATION OF TREAT-TO-TARGET FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS USING POOLED DATA FROM 3 PHASE III GOLIMUMAB CLINICAL TRIALS - Keystone, E.; Fleischmann, R.; Han, C.; Smolen, J.S.; Emery, P.; Genovese, M.; Gathany, T.; Doyle, M.; Hsia, E. (Value in Health, 2011)